Clover Health Investments, Corp. reported its financial results for the fourth quarter and full year 2024 on February 27, 2025. For Q4 2024, insurance revenue grew 9% year-over-year to $331 million, contributing to a full-year 2024 insurance revenue of $1.3 billion, also up 9% year-over-year.
The company significantly improved its GAAP Net loss from continuing operations, which was $21 million in Q4 2024 compared to $68 million in Q4 2023, and $46 million for full year 2024 compared to $210 million in 2023. Critically, full year 2024 Adjusted EBITDA reached a profit of $70 million, a substantial increase from a loss of $42 million in 2023.
Clover Health provided full-year 2025 guidance, projecting Medicare Advantage membership between 104,000 and 108,000, and insurance revenue between $1.800 billion and $1.875 billion. The company also maintained its Adjusted EBITDA guidance at $50 million to $70 million, reflecting confidence in sustained profitability and strategic investments in growth.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.